Loratadine blockade of K+ channels in human heart: Comparison with terfenadine under physiological conditions

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 1, 2000, Pages 261-264

  Crumb Jr , William J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LORATADINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; TERFENADINE;

ADULT; AGED; ARTICLE; CELL MEMBRANE DEPOLARIZATION; HEART ATRIUM MUSCLE; HUMAN; HUMAN TISSUE; PATCH CLAMP; PRIORITY JOURNAL;

ADULT; AGED; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART ATRIA; HISTAMINE H1 ANTAGONISTS; HUMANS; LORATADINE; MIDDLE AGED; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; TERFENADINE; TRANSFECTION;

EID: 0343485099     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Benedict CR (1993) The QT interval and drug-associated torsade de pointes. Drug Invest 5:69-79.
2. Bishop RO and Gaudry PL (1989) Prolonged Q-T interval following astemizole overdose. Arch Emerg Med 6:63-65.
3. + currents in cardiac cells: Comparison with terfenadine. Br J Pharmacol 124:663-668.
4. Craft TM (1985) Torsade de pointes after astemizole overdose. Br Med J 292:660.
5. Crumb WJ (1999) Rate-dependent blockade of a potassium current in human atrium by the antihistamine loratadine. Br J Pharmacol 126:575-580.
6. Crumb WJ, Pigott JD and Clarkson CW (1995a) Comparison of the transient outward current in young and adult human atrial myocytes: Evidence for developmental changes. Am J Physiol 268:H1335-H1342.
7. Crumb WJ, Pigott JD and Clarkson CW (1995b) Description of a nonselective cation current in human atrium. Circ Res 77:950-956.
8. Davies AJ, Harindra V, McEwan A and Ghose RR (1989) Cardiotoxic effect with convulsions in terfenadine overdose. Br Med J 298:325.
9. De Abajo FJ and Rodriguez LAG (1999) Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs. Br J Clin Pharmacol 47:307-313.
10. + channels. J Cardiovasc Pharmacol 30:42-54.
11. + channels. Circ Res 82:386-395.
12. Good AP, Rockwood R and Schad P (1994) Loratadine and ventricular tachycardia. Am J Cardiol 74:207.
13. Hamill OP, Marty A, Neher E, Sakmann B and Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pfluegers Arch 391:85-100.
14. Haria M, Fitton A and Peters DH (1994) Loratadine: A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 48:617-637.
15. Hilbert J, Moritzen V, Parks A, Radwanski E, Perentesis G, Symchowicz S and Zampaglione N (1988) The pharmacokinetics of loratadine in normal geriatric volunteers. J Intern Med Res 16:50-60.
16. Hilbert J, Radwanski E, Weglein R, Luc V, Perentesis G, Symchowicz S and Zampaglione N (1987) Pharmacokinetics and dose proportionality of loratadine. J Clin Pharmacol 27:694-698.
17. Jackman WN, Friday KJ, Anderson JL, Aliot EM, Clark M and Lazzara R (1988) The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 31:115-172.
18. + channel family by ebastine. J Pharmacol Exp Ther 281:233-244.
19. Lacerda AE, Roy ML, Lewis EW and Rampe D (1997) Interactions of the nonsedating antihistamme loratadine with a Kv1.5-like potassium channel cloned from human heart. Mol Pharmacol 52:314-322.
20. Lindquist M and Edwards IR (1997) Risks of non-sedating antihistamines. Lancet 349:1322.
21. Mays DJ, Foose JM, Philipson LH and Tamkun MM (1995) Localization of the Kv1.5 channel protein in explained cardiac tissue. J Clin Invest 96:282-292.
22. Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J and Cantilena LR (1990) Torsade de pointes occurring in association with terfenadine use. J Am Med Assoc 264:2788-2790.
23. + channel cloned from human heart. Mol Pharmacol 44:1240-1245.
24. Roy ML, Dumaine R and Brown AM (1996) HERG, a primary human ventricular target of the nonsedating antihistamme terfenadine. Circulation 94:817-823.
25. Salata JJ, Jurkiewicz NK, Wallace AA, Stupienski RF, Guinosso PJ MS and Lynch JJ (1995) Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res 76:110-119.
26. Stratmann HG and Kennedy HL (1987) Torsade de pointes associated with drugs and toxins: Recognition and management. Am Heart J 113:1481.
27. + channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines. Mol Pharmacol 54:113-121.
28. Kr: Implications for torsade de pointes and reverse use-dependence. Circulation 93:407-411.
29. Zehender M, Hohnloser S and Just H (1991) QT-interval prolonging drugs: Mechanisms and clinical relevance of their arrhythmogenic hazards. Cardiovasc Drugs Ther 5:515-530.
30. Zipes DP (1987) Proarrhythmic effects of antiarrhythmic drugs. Am J Cardiol 59:26E-31E.